{
  "paper_metadata": {
    "pmid": "31118583",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 172,
        "demographics": "Approximately 50% of patients had the Val30Met mutation; 67% had stage 1 disease (ambulating without assistance); 33% had stage 2 disease (ambulating with assistance); 58% previously received Diflunisal or Tafamidis, and 63% had cardiomyopathy.",
        "phenotype": "hereditary transthyretin amyloidosis (hATTR-PN)"
      },
      "penetrance_data": {
        "total_carriers_observed": 172,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Inotersen reduces levels of both mutated and wild-type TTR, effectively slowing or halting disease progression.",
        "assays": []
      },
      "segregation_data": "Penetrance is not complete, and there is a large variation in phenotype within genotypes.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met mutation is endemic in Portugal, Sweden, and Japan, with a large population in Brazil.",
      "key_quotes": [
        "Penetrance is not complete, and there is a large variation in phenotype within genotypes.",
        "The most common mutation is Val30Met, where valine is replaced by methionine at position 30 (148G\u2192A)."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364C>T",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "More common in the USA.",
        "phenotype": "predominant cardiac symptoms."
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Associated with predominant cardiac symptoms.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val122Ile mutation is associated with hATTR-CM.",
      "key_quotes": []
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.179C>G",
      "protein_notation": "p.Thr60Ala",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "More common in the USA.",
        "phenotype": "predominant cardiac symptoms."
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Associated with predominant cardiac symptoms.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Thr60Ala mutation is associated with hATTR-CM.",
      "key_quotes": []
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant variants in the TTR gene were extracted, with emphasis on penetrance data."
  }
}